Iovance Biotherapeutics Announces Pricing of Its Public Offering of Approximately $220 Million of Common Stock
Homerun Resources Inc. Engages DTEC Engineering to Advance Bankable Feasibility Study for the First Antimony-Free Solar Glass Project in the Americas